Spleen tyrosine kinase (Syk) plays a critical role in the immune system by mediating inflammatory responses and malignant neoplasms, which makes Syk become a promising drug treatment target for arthritis, asthma, and malignancies like leukemia and lymphoma (Geahlen, 2014). Here, SYK is linked to cancer.